RTW INVESTMENTS, LP - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$15,736,000
-85.6%
489,014
-79.2%
0.33%
-79.6%
Q4 2021$109,556,000
+72.4%
2,353,0150.0%1.60%
+67.0%
Q3 2021$63,531,000
+44.3%
2,353,015
+37.1%
0.96%
+44.3%
Q2 2021$44,030,000
-53.4%
1,716,585
-37.9%
0.66%
-55.0%
Q1 2021$94,432,000
+162.5%
2,762,791
+157.2%
1.47%
+144.0%
Q4 2020$35,975,000
+72.1%
1,074,166
+19.0%
0.60%
+20.1%
Q3 2020$20,904,000902,8550.50%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders